BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $1.50 per share versus the Zacks Consensus Estimate of a loss of$2.72. This compares to loss of $13.92 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 44.85$4.36 per share when it actually produced a loss of $3.57, delivering a surprise of 18.12%.Over the last four quarters, the company ...